Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,387
Total Claims
$1.6M
Drug Cost
570
Beneficiaries
$2,754
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,961 Nephrology providers
+115%
Cost per patient vs peers
$2,754 vs $1,283 avg
+96%
Brand preference vs peers
17.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.0%
Opioid Rate
229
Opioid Claims
$2,219
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,980 claims · $1.3M
Generic: 9,283 claims · $247K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 219 | $202K |
| Apixaban | 151 | $147K |
| Empagliflozin | 91 | $101K |
| Semaglutide | 79 | $95K |
| Sucroferric Oxyhydroxide | 11 | $53K |
| Liraglutide | 39 | $48K |
| Sitagliptin Phosphate | 55 | $40K |
| Lipase/Protease/Amylase | 18 | $38K |
| Insulin Glargine,hum.Rec.Anlog | 68 | $38K |
| Denosumab | 19 | $32K |
| Rivaroxaban | 37 | $29K |
| Linagliptin | 24 | $27K |
| Tirzepatide | 24 | $27K |
| Evolocumab | 28 | $25K |
| Dulaglutide | 16 | $24K |
Prescribing Profile
Patient Profile
76
Avg Age
57%
Female
2.44
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About